The annual incidence of cardiac sarcoidosis is low, but increased awareness of this inflammatory condition has led to earlier ...

Despite consistent improvements in glycemic outcomes across simulations, real-world adoption is lagging. The study finds that ...

Pioglitazone/metformin FDC with dapagliflozin may provide effective and safe management for Type 2 diabetes. Read more!

Use of Flash Continuous Glucose Monitoring is associated with A1C reduction in people with type 2 diabetes treated with basal insulin or noninsulin therapy. Diabetes Spectr. 2021;34(2):184-189. doi:10 ...

“This therapy isn’t for everybody ... He said patients should optimize their basal insulin dose and be willing to repeat using technosphere insulin 1 to 3 hours after a meal as well as ...

The older population can benefit from automated insulin delivery systems despite the stereotype saying that “technology is harder for older adults”, new research has underscored. A recent study from ...

Automated insulin delivery (AID) systems have been shown to be beneficial for patients with type 1 diabetes, but data are needed from randomized, controlled trials regarding their role in the ...

The places where you inject insulin may depend on the type of syringe or prefilled insulin pen you use. You should rotate these injection sites on your skin each time you inject insulin.

Hospitals and officials sounded an alarm this week, issuing a notice explaining which measles symptoms warranted immediate medical attention and stressing the importance of timely treatment.

The review also found that some people managed to reverse their need for insulin therapy during intermittent fasting while under the supervision of a healthcare professional. In addition to ...

These findings suggest that targeted therapies could complement insulin treatment, providing additional benefits in glycemic control and weight management,” Sulayman Patel, Pharma Analyst at ...

Mr. Modore is one of thousands of Kenyans, and hundreds of thousands of people worldwide, with TB who have lost access to treatments and testing in the weeks since the Trump administration slashed ...